Academic Journal
Impairment of neuronal activity occurs at the early stages of the aggregation cascade of Aβ1-42 and mutant Tau.
| Τίτλος: | Impairment of neuronal activity occurs at the early stages of the aggregation cascade of Aβ1-42 and mutant Tau. |
|---|---|
| Συγγραφείς: | Hirsch F; Department of Cell Biology, University of Bremen, Leobener Strasse 2, 28359 Bremen, Germany., F Läubli N; Molecular Neuroscience Group, Department of Chemical Engineering and Biotechnology, University of Cambridge, Philippa-Fawcett Drive, Cambridge CB3 0AS, UK., Kelkar A; Leibniz Institute on Aging - Fritz-Lipmann-Institute, Beutenbergstrasse 11, 07745 Jena, Germany., Sleiman M; Leibniz Institute on Aging - Fritz-Lipmann-Institute, Beutenbergstrasse 11, 07745 Jena, Germany., Woitzat Y; Leibniz Institute on Aging - Fritz-Lipmann-Institute, Beutenbergstrasse 11, 07745 Jena, Germany., Gallrein C; Leibniz Institute on Aging - Fritz-Lipmann-Institute, Beutenbergstrasse 11, 07745 Jena, Germany., Gumz V; Leibniz Institute on Aging - Fritz-Lipmann-Institute, Beutenbergstrasse 11, 07745 Jena, Germany., Kalsi GK; Leibniz Institute on Aging - Fritz-Lipmann-Institute, Beutenbergstrasse 11, 07745 Jena, Germany., Fernandez-Villegas A; Molecular Neuroscience Group, Department of Chemical Engineering and Biotechnology, University of Cambridge, Philippa-Fawcett Drive, Cambridge CB3 0AS, UK., Schierle GSK; Molecular Neuroscience Group, Department of Chemical Engineering and Biotechnology, University of Cambridge, Philippa-Fawcett Drive, Cambridge CB3 0AS, UK., Kirstein J; Leibniz Institute on Aging - Fritz-Lipmann-Institute, Beutenbergstrasse 11, 07745 Jena, Germany.; Friedrich-Schiller-Universität, Institute for Biochemistry & Biophysics, Hans Knöll-Strasse 2, 07745 Jena, Germany. |
| Πηγή: | Disease models & mechanisms [Dis Model Mech] 2026 Mar 01; Vol. 19 (3). Date of Electronic Publication: 2026 Apr 01. |
| Τύπος έκδοσης: | Journal Article |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: Company of Biologists Ltd Country of Publication: England NLM ID: 101483332 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1754-8411 (Electronic) Linking ISSN: 17548403 NLM ISO Abbreviation: Dis Model Mech Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: Cambridge : Company of Biologists Ltd., c2008- |
| Ιατρικοί όροι (MeSH): | Amyloid beta-Peptides*/metabolism , tau Proteins*/metabolism , tau Proteins*/genetics , Neurons*/metabolism , Neurons*/pathology , Mutation*/genetics , Peptide Fragments*/metabolism , Mutant Proteins*/metabolism , Protein Aggregates* , Protein Aggregation, Pathological*, Caenorhabditis elegans/metabolism ; Aging/pathology ; Aging/metabolism ; Muscles/metabolism ; Muscles/pathology ; Calcium/metabolism ; Alzheimer Disease/metabolism ; Alzheimer Disease/pathology ; Animals ; Proteotoxic Stress |
| Περίληψη: | Alzheimer's disease (AD) is a progressive neurodegenerative disease that is characterized by the accumulation of amyloid-β (Aβ) plaques and neurofibrillary Tau tangles, ultimately leading to brain atrophy and death. To elucidate the relationship between the aberrant folding and aggregation of Aβ and mutant Tau and neuronal function, we monitored neuronal activity in C. elegans AD models across age. For that, we used a neuronal GCaMP reporter to monitor fluctuations in Ca2+ and developed microfluidic devices to immobilize nematodes to non-invasively assess neuronal activity. Our findings revealed that expression of both Aβ and Tau lead to significant reductions in neuronal activity and function in young adult animals, preceding the accumulation of amyloid aggregates. Notably, Aβ expression and aggregation in muscle tissue produced detrimental effects on neuronal activity comparable to those seen after expression in neurons, suggesting that proteotoxic stress in muscle can influence neuronal function. This may occur through propagation of Aβ from muscle to neurons or through retrograde signaling pathways. Further, our new sub-stoichiometrically labeled Tau strains highlight the significant impact TauP301L,V337M has on neuronal activity throughout aging. These results enhance our understanding of the early functional effects of amyloid aggregation in Alzheimer's disease. (© 2026. Published by The Company of Biologists.) |
| Competing Interests: | Competing interests The authors declare no competing or financial interests. |
| Σχόλια: | Update of: bioRxiv. 2025 Jul 24:2025.07.21.665894. doi: 10.1101/2025.07.21.665894.. (PMID: 40777286) |
| References: | Gene. 1999 Mar 18;229(1-2):31-5. (PMID: 10095101) Front Aging Neurosci. 2022 Jul 06;14:946297. (PMID: 35928998) Nano Lett. 2017 Jan 11;17(1):143-149. (PMID: 28073262) Nature. 2006 May 4;441(7089):91-5. (PMID: 16672971) Science. 2017 Jun 23;356(6344):. (PMID: 28642382) J Cell Sci. 2013 May 1;126(Pt 9):2079-91. (PMID: 23525010) Prog Neurobiol. 2021 Mar;198:101907. (PMID: 32926945) PLoS One. 2013 May 22;8(5):e64297. (PMID: 23717588) Front Aging. 2022 Aug 19;3:928574. (PMID: 36062211) Am J Pathol. 2000 Jul;157(1):277-86. (PMID: 10880397) J Cell Sci. 1996 Nov;109 ( Pt 11):2661-72. (PMID: 8937984) Cell. 2010 Nov 24;143(5):813-25. (PMID: 21111239) Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):9980-5. (PMID: 12872001) Transl Psychiatry. 2022 Jun 22;12(1):257. (PMID: 35732622) Dev Cell. 2017 Jan 23;40(2):202-214. (PMID: 28041904) PLoS One. 2014 Dec 03;9(12):e113917. (PMID: 25470130) Front Physiol. 2023 Jul 04;14:1228490. (PMID: 37469564) Nat Commun. 2021 May 10;12(1):2583. (PMID: 33972516) J Biol Methods. 2014;1(2):. (PMID: 25606571) Hum Mol Genet. 2012 Aug 15;21(16):3587-603. (PMID: 22611162) Neurobiol Dis. 2005 Nov;20(2):372-83. (PMID: 16242642) Nat Commun. 2016 Oct 11;7:13023. (PMID: 27725672) J Biol Chem. 2009 Mar 6;284(10):6021-5. (PMID: 18948254) Nature. 2013 Jul 18;499(7458):295-300. (PMID: 23868258) Nat Rev Mol Cell Biol. 2014 Mar;15(3):211-7. (PMID: 24556842) Lab Chip. 2007 Nov;7(11):1515-23. (PMID: 17960280) CNS Neurosci Ther. 2011 Oct;17(5):514-24. (PMID: 20553310) Oncotarget. 2016 Aug 30;7(35):56147-56152. (PMID: 27528229) Lab Chip. 2010 Jul 21;10(14):1862-8. (PMID: 20461264) Biochemistry. 2004 Feb 17;43(6):1694-703. (PMID: 14769047) Neurobiol Dis. 2018 Sep;117:226-234. (PMID: 29936232) Development. 2003 Aug;130(16):3781-94. (PMID: 12835394) Lab Chip. 2009 Jan 7;9(1):151-7. (PMID: 19209348) Mol Neurodegener. 2016 Apr 27;11:33. (PMID: 27118310) WormBook. 2013 Sep 24;:1-19. (PMID: 24065448) Cell. 2013 Jun 6;153(6):1366-78. (PMID: 23746847) Front Mol Neurosci. 2021 Oct 15;14:721749. (PMID: 34720872) Ann Med. 1989;21(2):127-32. (PMID: 2504257) Molecules. 2019 Nov 25;24(23):. (PMID: 31775328) PLoS One. 2013 Oct 09;8(10):e76019. (PMID: 24130756) Lab Chip. 2012 Jun 21;12(12):2211-20. (PMID: 22588281) Neuron. 2007 Feb 1;53(3):337-51. (PMID: 17270732) Neuron. 2017 Feb 8;93(3):533-541.e5. (PMID: 28111080) Proc Natl Acad Sci U S A. 2007 Aug 28;104(35):13891-5. (PMID: 17715055) Neurology. 2005 Aug 9;65(3):404-11. (PMID: 16087905) Nat Neurosci. 1999 Nov;2(11):959-64. (PMID: 10526333) N Engl J Med. 2000 Aug 17;343(7):450-6. (PMID: 10944562) J Vis Exp. 2020 Mar 27;(157):. (PMID: 32281971) Am J Pathol. 2007 Sep;171(3):976-92. (PMID: 17690183) Cold Spring Harb Protoc. 2012 Jun 01;2012(6):647-56. (PMID: 22661439) |
| Grant Information: | KI1988/7-1 Deutsche Forschungsgemeinschaft; MR/K02292X/1 United Kingdom MRF_ MRF_; ARUK-PG013-14 Alzheimer's Research UK; 20052CB Alzheimer Forschung Initiative; Universität Bremen; KI1988/7-1 Deutsche Forschungsgemeinschaft (DFG); 065807/Z/01/Z United Kingdom WT_ Wellcome Trust; 203249/Z/16/Z United Kingdom WT_ Wellcome Trust; MR/K02292X/1 Medical Research Council (MRC); ARUK-PG013-14 Alzheimer Research UK (ARUK); 16238 Michael J. Fox Foundation |
| Contributed Indexing: | Keywords: C. elegans; Abeta; Aging; Alzheimers disease; Neurodegeneration; Tau |
| Substance Nomenclature: | 0 (Amyloid beta-Peptides) 0 (tau Proteins) 0 (amyloid beta-protein (1-42)) 0 (Peptide Fragments) 0 (Protein Aggregates) 0 (Mutant Proteins) SY7Q814VUP (Calcium) |
| Entry Date(s): | Date Created: 20260223 Date Completed: 20260708 Latest Revision: 20260813 |
| Update Code: | 20260813 |
| PubMed Central ID: | PMC13072132 |
| DOI: | 10.1242/dmm.052295 |
| PMID: | 41725344 |
| Βάση Δεδομένων: | MEDLINE |
| FullText | Text: Availability: 0 CustomLinks: – Url: https://resolver.ebsco.com/c/fiv2js/result?sid=EBSCO:cmedm&genre=article&issn=17548411&ISBN=&volume=19&issue=3&date=20260301&spage=&pages=&title=Disease models & mechanisms&atitle=Impairment%20of%20neuronal%20activity%20occurs%20at%20the%20early%20stages%20of%20the%20aggregation%20cascade%20of%20A%CE%B21-42%20and%20mutant%20Tau.&aulast=Hirsch%20F&id=DOI:10.1242/dmm.052295 Name: Full Text Finder (for New FTF UI) (ns324271) Category: fullText Text: Full Text Finder MouseOverText: Full Text Finder |
|---|---|
| Header | DbId: cmedm DbLabel: MEDLINE An: 41725344 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Impairment of neuronal activity occurs at the early stages of the aggregation cascade of Aβ1-42 and mutant Tau. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Hirsch+F%22">Hirsch F</searchLink>; Department of Cell Biology, University of Bremen, Leobener Strasse 2, 28359 Bremen, Germany.<br /><searchLink fieldCode="AU" term="%22F+Läubli+N%22">F Läubli N</searchLink>; Molecular Neuroscience Group, Department of Chemical Engineering and Biotechnology, University of Cambridge, Philippa-Fawcett Drive, Cambridge CB3 0AS, UK.<br /><searchLink fieldCode="AU" term="%22Kelkar+A%22">Kelkar A</searchLink>; Leibniz Institute on Aging - Fritz-Lipmann-Institute, Beutenbergstrasse 11, 07745 Jena, Germany.<br /><searchLink fieldCode="AU" term="%22Sleiman+M%22">Sleiman M</searchLink>; Leibniz Institute on Aging - Fritz-Lipmann-Institute, Beutenbergstrasse 11, 07745 Jena, Germany.<br /><searchLink fieldCode="AU" term="%22Woitzat+Y%22">Woitzat Y</searchLink>; Leibniz Institute on Aging - Fritz-Lipmann-Institute, Beutenbergstrasse 11, 07745 Jena, Germany.<br /><searchLink fieldCode="AU" term="%22Gallrein+C%22">Gallrein C</searchLink>; Leibniz Institute on Aging - Fritz-Lipmann-Institute, Beutenbergstrasse 11, 07745 Jena, Germany.<br /><searchLink fieldCode="AU" term="%22Gumz+V%22">Gumz V</searchLink>; Leibniz Institute on Aging - Fritz-Lipmann-Institute, Beutenbergstrasse 11, 07745 Jena, Germany.<br /><searchLink fieldCode="AU" term="%22Kalsi+GK%22">Kalsi GK</searchLink>; Leibniz Institute on Aging - Fritz-Lipmann-Institute, Beutenbergstrasse 11, 07745 Jena, Germany.<br /><searchLink fieldCode="AU" term="%22Fernandez-Villegas+A%22">Fernandez-Villegas A</searchLink>; Molecular Neuroscience Group, Department of Chemical Engineering and Biotechnology, University of Cambridge, Philippa-Fawcett Drive, Cambridge CB3 0AS, UK.<br /><searchLink fieldCode="AU" term="%22Schierle+GSK%22">Schierle GSK</searchLink>; Molecular Neuroscience Group, Department of Chemical Engineering and Biotechnology, University of Cambridge, Philippa-Fawcett Drive, Cambridge CB3 0AS, UK.<br /><searchLink fieldCode="AU" term="%22Kirstein+J%22">Kirstein J</searchLink>; Leibniz Institute on Aging - Fritz-Lipmann-Institute, Beutenbergstrasse 11, 07745 Jena, Germany.; Friedrich-Schiller-Universität, Institute for Biochemistry & Biophysics, Hans Knöll-Strasse 2, 07745 Jena, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101483332%22">Disease models & mechanisms</searchLink> [Dis Model Mech] 2026 Mar 01; Vol. 19 (3). <i>Date of Electronic Publication: </i>2026 Apr 01. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: Language Label: Language Group: Lang Data: English – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Company+of+Biologists+Ltd%22">Company of Biologists Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101483332 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1754-8411 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217548403%22">17548403 </searchLink><i>NLM ISO Abbreviation: </i>Dis Model Mech <i>Subsets: </i>MEDLINE – Name: PublisherInfo Label: Imprint Name(s) Group: PubInfo Data: <i>Original Publication</i>: Cambridge : Company of Biologists Ltd., c2008- – Name: SubjectMESH Label: MeSH Terms Group: Su Data: <searchLink fieldCode="MM" term="%22Amyloid+beta-Peptides%22">Amyloid beta-Peptides*</searchLink>/<searchLink fieldCode="MM" term="%22Amyloid+beta-Peptides+metabolism%22">metabolism</searchLink> <br /><searchLink fieldCode="MM" term="%22tau+Proteins%22">tau Proteins*</searchLink>/<searchLink fieldCode="MM" term="%22tau+Proteins+metabolism%22">metabolism</searchLink> <br /><searchLink fieldCode="MM" term="%22tau+Proteins%22">tau Proteins*</searchLink>/<searchLink fieldCode="MM" term="%22tau+Proteins+genetics%22">genetics</searchLink> <br /><searchLink fieldCode="MM" term="%22Neurons%22">Neurons*</searchLink>/<searchLink fieldCode="MM" term="%22Neurons+metabolism%22">metabolism</searchLink> <br /><searchLink fieldCode="MM" term="%22Neurons%22">Neurons*</searchLink>/<searchLink fieldCode="MM" term="%22Neurons+pathology%22">pathology</searchLink> <br /><searchLink fieldCode="MM" term="%22Mutation%22">Mutation*</searchLink>/<searchLink fieldCode="MM" term="%22Mutation+genetics%22">genetics</searchLink> <br /><searchLink fieldCode="MM" term="%22Peptide+Fragments%22">Peptide Fragments*</searchLink>/<searchLink fieldCode="MM" term="%22Peptide+Fragments+metabolism%22">metabolism</searchLink> <br /><searchLink fieldCode="MM" term="%22Mutant+Proteins%22">Mutant Proteins*</searchLink>/<searchLink fieldCode="MM" term="%22Mutant+Proteins+metabolism%22">metabolism</searchLink> <br /><searchLink fieldCode="MM" term="%22Protein+Aggregates%22">Protein Aggregates*</searchLink> <br /><searchLink fieldCode="MM" term="%22Protein+Aggregation%2C+Pathological%22">Protein Aggregation, Pathological*</searchLink><br /><searchLink fieldCode="MH" term="%22Caenorhabditis+elegans%22">Caenorhabditis elegans</searchLink>/<searchLink fieldCode="MH" term="%22Caenorhabditis+elegans+metabolism%22">metabolism</searchLink> ; <searchLink fieldCode="MH" term="%22Aging%22">Aging</searchLink>/<searchLink fieldCode="MH" term="%22Aging+pathology%22">pathology</searchLink> ; <searchLink fieldCode="MH" term="%22Aging%22">Aging</searchLink>/<searchLink fieldCode="MH" term="%22Aging+metabolism%22">metabolism</searchLink> ; <searchLink fieldCode="MH" term="%22Muscles%22">Muscles</searchLink>/<searchLink fieldCode="MH" term="%22Muscles+metabolism%22">metabolism</searchLink> ; <searchLink fieldCode="MH" term="%22Muscles%22">Muscles</searchLink>/<searchLink fieldCode="MH" term="%22Muscles+pathology%22">pathology</searchLink> ; <searchLink fieldCode="MH" term="%22Calcium%22">Calcium</searchLink>/<searchLink fieldCode="MH" term="%22Calcium+metabolism%22">metabolism</searchLink> ; <searchLink fieldCode="MH" term="%22Alzheimer+Disease%22">Alzheimer Disease</searchLink>/<searchLink fieldCode="MH" term="%22Alzheimer+Disease+metabolism%22">metabolism</searchLink> ; <searchLink fieldCode="MH" term="%22Alzheimer+Disease%22">Alzheimer Disease</searchLink>/<searchLink fieldCode="MH" term="%22Alzheimer+Disease+pathology%22">pathology</searchLink> ; <searchLink fieldCode="MH" term="%22Animals%22">Animals</searchLink> ; <searchLink fieldCode="MH" term="%22Proteotoxic+Stress%22">Proteotoxic Stress</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Alzheimer's disease (AD) is a progressive neurodegenerative disease that is characterized by the accumulation of amyloid-β (Aβ) plaques and neurofibrillary Tau tangles, ultimately leading to brain atrophy and death. To elucidate the relationship between the aberrant folding and aggregation of Aβ and mutant Tau and neuronal function, we monitored neuronal activity in C. elegans AD models across age. For that, we used a neuronal GCaMP reporter to monitor fluctuations in Ca2+ and developed microfluidic devices to immobilize nematodes to non-invasively assess neuronal activity. Our findings revealed that expression of both Aβ and Tau lead to significant reductions in neuronal activity and function in young adult animals, preceding the accumulation of amyloid aggregates. Notably, Aβ expression and aggregation in muscle tissue produced detrimental effects on neuronal activity comparable to those seen after expression in neurons, suggesting that proteotoxic stress in muscle can influence neuronal function. This may occur through propagation of Aβ from muscle to neurons or through retrograde signaling pathways. Further, our new sub-stoichiometrically labeled Tau strains highlight the significant impact TauP301L,V337M has on neuronal activity throughout aging. These results enhance our understanding of the early functional effects of amyloid aggregation in Alzheimer's disease.<br /> (© 2026. Published by The Company of Biologists.) – Name: Abstract Label: Competing Interests Group: Ab Data: Competing interests The authors declare no competing or financial interests. – Name: Comment Label: Comments Group: Commnt Data: Update of: bioRxiv. 2025 Jul 24:2025.07.21.665894. doi: 10.1101/2025.07.21.665894.. (PMID: <searchLink fieldCode="PM" term="%2240777286%22">40777286)</searchLink> – Name: Ref Label: References Group: RefInfo Data: Gene. 1999 Mar 18;229(1-2):31-5. (PMID: <searchLink fieldCode="PM" term="%2210095101%22">10095101)</searchLink><br />Front Aging Neurosci. 2022 Jul 06;14:946297. (PMID: <searchLink fieldCode="PM" term="%2235928998%22">35928998)</searchLink><br />Nano Lett. 2017 Jan 11;17(1):143-149. (PMID: <searchLink fieldCode="PM" term="%2228073262%22">28073262)</searchLink><br />Nature. 2006 May 4;441(7089):91-5. (PMID: <searchLink fieldCode="PM" term="%2216672971%22">16672971)</searchLink><br />Science. 2017 Jun 23;356(6344):. (PMID: <searchLink fieldCode="PM" term="%2228642382%22">28642382)</searchLink><br />J Cell Sci. 2013 May 1;126(Pt 9):2079-91. (PMID: <searchLink fieldCode="PM" term="%2223525010%22">23525010)</searchLink><br />Prog Neurobiol. 2021 Mar;198:101907. (PMID: <searchLink fieldCode="PM" term="%2232926945%22">32926945)</searchLink><br />PLoS One. 2013 May 22;8(5):e64297. (PMID: <searchLink fieldCode="PM" term="%2223717588%22">23717588)</searchLink><br />Front Aging. 2022 Aug 19;3:928574. (PMID: <searchLink fieldCode="PM" term="%2236062211%22">36062211)</searchLink><br />Am J Pathol. 2000 Jul;157(1):277-86. (PMID: <searchLink fieldCode="PM" term="%2210880397%22">10880397)</searchLink><br />J Cell Sci. 1996 Nov;109 ( Pt 11):2661-72. (PMID: <searchLink fieldCode="PM" term="%228937984%22">8937984)</searchLink><br />Cell. 2010 Nov 24;143(5):813-25. (PMID: <searchLink fieldCode="PM" term="%2221111239%22">21111239)</searchLink><br />Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):9980-5. (PMID: <searchLink fieldCode="PM" term="%2212872001%22">12872001)</searchLink><br />Transl Psychiatry. 2022 Jun 22;12(1):257. (PMID: <searchLink fieldCode="PM" term="%2235732622%22">35732622)</searchLink><br />Dev Cell. 2017 Jan 23;40(2):202-214. (PMID: <searchLink fieldCode="PM" term="%2228041904%22">28041904)</searchLink><br />PLoS One. 2014 Dec 03;9(12):e113917. (PMID: <searchLink fieldCode="PM" term="%2225470130%22">25470130)</searchLink><br />Front Physiol. 2023 Jul 04;14:1228490. (PMID: <searchLink fieldCode="PM" term="%2237469564%22">37469564)</searchLink><br />Nat Commun. 2021 May 10;12(1):2583. (PMID: <searchLink fieldCode="PM" term="%2233972516%22">33972516)</searchLink><br />J Biol Methods. 2014;1(2):. (PMID: <searchLink fieldCode="PM" term="%2225606571%22">25606571)</searchLink><br />Hum Mol Genet. 2012 Aug 15;21(16):3587-603. (PMID: <searchLink fieldCode="PM" term="%2222611162%22">22611162)</searchLink><br />Neurobiol Dis. 2005 Nov;20(2):372-83. (PMID: <searchLink fieldCode="PM" term="%2216242642%22">16242642)</searchLink><br />Nat Commun. 2016 Oct 11;7:13023. (PMID: <searchLink fieldCode="PM" term="%2227725672%22">27725672)</searchLink><br />J Biol Chem. 2009 Mar 6;284(10):6021-5. (PMID: <searchLink fieldCode="PM" term="%2218948254%22">18948254)</searchLink><br />Nature. 2013 Jul 18;499(7458):295-300. (PMID: <searchLink fieldCode="PM" term="%2223868258%22">23868258)</searchLink><br />Nat Rev Mol Cell Biol. 2014 Mar;15(3):211-7. (PMID: <searchLink fieldCode="PM" term="%2224556842%22">24556842)</searchLink><br />Lab Chip. 2007 Nov;7(11):1515-23. (PMID: <searchLink fieldCode="PM" term="%2217960280%22">17960280)</searchLink><br />CNS Neurosci Ther. 2011 Oct;17(5):514-24. (PMID: <searchLink fieldCode="PM" term="%2220553310%22">20553310)</searchLink><br />Oncotarget. 2016 Aug 30;7(35):56147-56152. (PMID: <searchLink fieldCode="PM" term="%2227528229%22">27528229)</searchLink><br />Lab Chip. 2010 Jul 21;10(14):1862-8. (PMID: <searchLink fieldCode="PM" term="%2220461264%22">20461264)</searchLink><br />Biochemistry. 2004 Feb 17;43(6):1694-703. (PMID: <searchLink fieldCode="PM" term="%2214769047%22">14769047)</searchLink><br />Neurobiol Dis. 2018 Sep;117:226-234. (PMID: <searchLink fieldCode="PM" term="%2229936232%22">29936232)</searchLink><br />Development. 2003 Aug;130(16):3781-94. (PMID: <searchLink fieldCode="PM" term="%2212835394%22">12835394)</searchLink><br />Lab Chip. 2009 Jan 7;9(1):151-7. (PMID: <searchLink fieldCode="PM" term="%2219209348%22">19209348)</searchLink><br />Mol Neurodegener. 2016 Apr 27;11:33. (PMID: <searchLink fieldCode="PM" term="%2227118310%22">27118310)</searchLink><br />WormBook. 2013 Sep 24;:1-19. (PMID: <searchLink fieldCode="PM" term="%2224065448%22">24065448)</searchLink><br />Cell. 2013 Jun 6;153(6):1366-78. (PMID: <searchLink fieldCode="PM" term="%2223746847%22">23746847)</searchLink><br />Front Mol Neurosci. 2021 Oct 15;14:721749. (PMID: <searchLink fieldCode="PM" term="%2234720872%22">34720872)</searchLink><br />Ann Med. 1989;21(2):127-32. (PMID: <searchLink fieldCode="PM" term="%222504257%22">2504257)</searchLink><br />Molecules. 2019 Nov 25;24(23):. (PMID: <searchLink fieldCode="PM" term="%2231775328%22">31775328)</searchLink><br />PLoS One. 2013 Oct 09;8(10):e76019. (PMID: <searchLink fieldCode="PM" term="%2224130756%22">24130756)</searchLink><br />Lab Chip. 2012 Jun 21;12(12):2211-20. (PMID: <searchLink fieldCode="PM" term="%2222588281%22">22588281)</searchLink><br />Neuron. 2007 Feb 1;53(3):337-51. (PMID: <searchLink fieldCode="PM" term="%2217270732%22">17270732)</searchLink><br />Neuron. 2017 Feb 8;93(3):533-541.e5. (PMID: <searchLink fieldCode="PM" term="%2228111080%22">28111080)</searchLink><br />Proc Natl Acad Sci U S A. 2007 Aug 28;104(35):13891-5. (PMID: <searchLink fieldCode="PM" term="%2217715055%22">17715055)</searchLink><br />Neurology. 2005 Aug 9;65(3):404-11. (PMID: <searchLink fieldCode="PM" term="%2216087905%22">16087905)</searchLink><br />Nat Neurosci. 1999 Nov;2(11):959-64. (PMID: <searchLink fieldCode="PM" term="%2210526333%22">10526333)</searchLink><br />N Engl J Med. 2000 Aug 17;343(7):450-6. (PMID: <searchLink fieldCode="PM" term="%2210944562%22">10944562)</searchLink><br />J Vis Exp. 2020 Mar 27;(157):. (PMID: <searchLink fieldCode="PM" term="%2232281971%22">32281971)</searchLink><br />Am J Pathol. 2007 Sep;171(3):976-92. (PMID: <searchLink fieldCode="PM" term="%2217690183%22">17690183)</searchLink><br />Cold Spring Harb Protoc. 2012 Jun 01;2012(6):647-56. (PMID: <searchLink fieldCode="PM" term="%2222661439%22">22661439)</searchLink> – Name: GrantInfo Label: Grant Information Group: Grant Data: KI1988/7-1 Deutsche Forschungsgemeinschaft; MR/K02292X/1 United Kingdom MRF_ MRF_; ARUK-PG013-14 Alzheimer's Research UK; 20052CB Alzheimer Forschung Initiative; Universität Bremen; KI1988/7-1 Deutsche Forschungsgemeinschaft (DFG); 065807/Z/01/Z United Kingdom WT_ Wellcome Trust; 203249/Z/16/Z United Kingdom WT_ Wellcome Trust; MR/K02292X/1 Medical Research Council (MRC); ARUK-PG013-14 Alzheimer Research UK (ARUK); 16238 Michael J. Fox Foundation – Name: SubjectMinor Label: Contributed Indexing Group: Data: <i>Keywords: </i>C. elegans; Abeta; Aging; Alzheimers disease; Neurodegeneration; Tau – Name: NumberCAS Label: Substance Nomenclature Group: ID Data: 0 (Amyloid beta-Peptides)<br />0 (tau Proteins)<br />0 (amyloid beta-protein (1-42))<br />0 (Peptide Fragments)<br />0 (Protein Aggregates)<br />0 (Mutant Proteins)<br />SY7Q814VUP (Calcium) – Name: DateEntry Label: Entry Date(s) Group: Date Data: <i>Date Created: </i>20260223 <i>Date Completed: </i>20260708 <i>Latest Revision: </i>20260813 – Name: DateUpdate Label: Update Code Group: Date Data: 20260813 – Name: PubmedCentralID Label: PubMed Central ID Group: ID Data: PMC13072132 – Name: DOI Label: DOI Group: ID Data: 10.1242/dmm.052295 – Name: AN Label: PMID Group: ID Data: 41725344 |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=cmedm&AN=41725344 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1242/dmm.052295 Languages: – Code: eng Text: English Subjects: – SubjectFull: Caenorhabditis elegans metabolism Type: general – SubjectFull: Aging pathology Type: general – SubjectFull: Aging metabolism Type: general – SubjectFull: Muscles metabolism Type: general – SubjectFull: Muscles pathology Type: general – SubjectFull: Calcium metabolism Type: general – SubjectFull: Alzheimer Disease metabolism Type: general – SubjectFull: Alzheimer Disease pathology Type: general – SubjectFull: Animals Type: general – SubjectFull: Proteotoxic Stress Type: general – SubjectFull: Amyloid beta-Peptides metabolism Type: general – SubjectFull: tau Proteins metabolism Type: general – SubjectFull: tau Proteins genetics Type: general – SubjectFull: Neurons metabolism Type: general – SubjectFull: Neurons pathology Type: general – SubjectFull: Mutation genetics Type: general – SubjectFull: Peptide Fragments metabolism Type: general – SubjectFull: Mutant Proteins metabolism Type: general – SubjectFull: Protein Aggregates Type: general – SubjectFull: Protein Aggregation, Pathological Type: general Titles: – TitleFull: Impairment of neuronal activity occurs at the early stages of the aggregation cascade of Aβ1-42 and mutant Tau. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hirsch F – PersonEntity: Name: NameFull: F Läubli N – PersonEntity: Name: NameFull: Kelkar A – PersonEntity: Name: NameFull: Sleiman M – PersonEntity: Name: NameFull: Woitzat Y – PersonEntity: Name: NameFull: Gallrein C – PersonEntity: Name: NameFull: Gumz V – PersonEntity: Name: NameFull: Kalsi GK – PersonEntity: Name: NameFull: Fernandez-Villegas A – PersonEntity: Name: NameFull: Schierle GSK – PersonEntity: Name: NameFull: Kirstein J IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2026 Mar 01 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1754-8411 Numbering: – Type: volume Value: 19 – Type: issue Value: 3 Titles: – TitleFull: Disease models & mechanisms Type: main |
| ResultId | 1 |